NCT02058017View on ClinicalTrials.gov

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

PHASE1TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

OPB-51602

Trial Locations (1)

119228

National University Hospital, Singapore, Singapore

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

collaborator

Shin Nippon Biomedical Laboratories, Ltd.

INDUSTRY

lead

National University Hospital, Singapore

OTHER